In the US, the third and final stage of testing of the coronavirus vaccine by the American biotechnology company Moderna has begun. This is stated in a message published on the company’s website.
Participants in the clinical trials will be 30 thousand people. It will be conducted using the method of a randomized placebo-controlled study in the ratio of 1: 1.
According to the Associated Press, this will be the largest clinical trial of the SARS-CoV-2 coronavirus vaccine in the world.
To create the vaccine, Moderna received $ 483 million from the Department of medico biological research of the US Department of health. At the same time, it was assumed that the third phase of clinical trials would take place on a relatively small number of volunteers.
However, during discussions and consultations with the Food and Drug Administration, the parties decided to increase the scale of testing in the third phase significantly. For this purpose, the company has allocated an additional $ 472 million.